We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $71.3B
1-Year Est. Return 56.8%
This Fund
S&P 500
This Quarter Est. Return
+24.89%
1 Year Est. Return
+56.8%
3 Year Est. Return
+170.28%
5 Year Est. Return
+249.16%
10 Year Est. Return
+1,007.9%
AUM
$71.3B
AUM Growth
+$6.48B
Cap. Flow
-$2.43B
Cap. Flow %
-3.41%
Top 10 Hldgs %
29.48%
Holding
1,130
New
174
Increased
291
Reduced
392
Closed
128

Top Buys

Rank Stock Value
1
DVN icon
Devon Energy
DVN
+$353M
2
MRVL icon
Marvell Technology
MRVL
+$150M
3
SYRE icon
Spyre Therapeutics
SYRE
+$126M
4
BBIO icon
BridgeBio Pharma
BBIO
+$116M
5
DOV icon
Dover
DOV
+$110M

Top Sells

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$713M
2
CNTA
Centessa Pharmaceuticals
CNTA
+$355M
3
CTRA
Coterra Energy
CTRA
+$289M
4
RPRX icon
Royalty Pharma
RPRX
+$259M
5
LLY icon
Eli Lilly
LLY
+$236M

Sector Composition

Rank Sector Weight
1 Technology 32.29%
2 Healthcare 14.03%
3 Financials 12.39%
4 Industrials 8.94%
5 Communication Services 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HUBS icon
526
HubSpot
HUBS
$11.5B
$18.3M 0.03%
100,000
-50,000
-33% -$10.5M
DSAC
527
Daedalus Special Acquisition Corp
DSAC
$347M
$18.2M 0.03%
1,800,000
– –
AES icon
528
AES
AES
$10.6B
$18.1M 0.03%
1,235,612
-1,349,700
-52% -$19.6M
XENE icon
529
Xenon Pharmaceuticals
XENE
$5.71B
$18.1M 0.03%
300,000
-170,000
-36% -$9.44M
SAC
530
Safeguard Acquisition Corp
SAC
$317M
$18.1M 0.03%
1,800,000
– –
YICCU
531
Yorkville International Capital Corp Units
YICCU
$18.1M 0.03%
+1,800,000
New +$18.1M
DNTH icon
532
Dianthus Therapeutics
DNTH
$5.99B
$18M 0.03%
185,000
+25,000
+16% +$2.18M
IFF icon
533
International Flavors & Fragrances
IFF
$21.5B
$18M 0.03%
227,500
-1,000
-0.4% -$74.4K
ARCI
534
Archimedes Tech SPAC Partners III
ARCI
$356M
$18M 0.03%
1,800,000
– –
TMTS
535
Spartacus Acquisition Corp II
TMTS
$309M
$18M 0.03%
+1,800,000
New +$18M
ISNRU
536
Snow Rothschild Acquisition Corp Units
ISNRU
$18M 0.03%
+1,800,000
New +$18M
GPAC
537
General Purpose Acquisition Corp
GPAC
$296M
$18M 0.03%
1,800,000
– –
AEAQ
538
Activate Energy Acquisition Corp
AEAQ
$316M
$18M 0.03%
1,800,000
– –
XCBE
539
X3 Acquisition Corp
XCBE
$281M
$18M 0.03%
1,800,000
– –
SHOTU
540
RMG ML Sports Holdings Unit
SHOTU
$202M
$18M 0.03%
+1,800,000
New +$18M
IP icon
541
International Paper
IP
$18.3B
$18M 0.03%
471,892
+151,200
+47% +$5.18M
NWSA icon
542
News Corp Class A
NWSA
$15.9B
$18M 0.03%
723,676
-344,844
-32% -$8.94M
KPET
543
KPET Ultra Paceline Corp
KPET
$289M
$18M 0.03%
+1,800,000
New +$18M
ACGC
544
ACP Holdings Acquisition Corp
ACGC
$292M
$17.9M 0.03%
+1,800,000
New +$17.9M
FGII
545
FG Imperii Acquisition Corp
FGII
$290M
$17.9M 0.03%
1,800,000
– –
LEGO
546
Legato Merger Corp IV
LEGO
$312M
$17.9M 0.03%
1,800,000
– –
CAQ
547
Cambridge Acquisition Corp
CAQ
$313M
$17.8M 0.03%
+1,800,000
New +$17.8M
AACO
548
Abony Acquisition Corp I
AACO
$313M
$17.8M 0.03%
+1,800,000
New +$17.8M
TRGS
549
TRG Latin America Acquisitions Corp
TRGS
$17.8M 0.03%
+1,800,000
New +$17.8M
ASND icon
550
Ascendis Pharma A/S
ASND
$17.1B
$17.7M 0.02%
+66,500
New +$15.5M
20 21
22
23 24

Similar funds

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $72.2B AUM 27.85% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $70.2B AUM 30.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

Adage Capital Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Adage Capital Partners held 1,130 positions worth $71.3B, up 10% from $64.8B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Adage Capital Partners withdrew a net $2.43B in Q2 2026, closing 128 positions and reducing 392 holdings. Its most notable exit was Centessa Pharmaceuticals, an estimated $355M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Adage Capital Partners opened a new position in Marvell Technology worth $222M.

  • Adage Capital Partners's largest Q2 2026 buy was Marvell Technology: 745,800 shares worth $222M.
  • Adage Capital Partners added most to Devon Energy in Q2 2026, an estimated $353M increase.
  • Adage Capital Partners's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $713M.
  • Adage Capital Partners fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $355M.
  • Adage Capital Partners's ten largest holdings make up 29% of its $71.3B portfolio in Q2 2026.
  • Adage Capital Partners opened 174 new positions and closed 128 in Q2 2026.
  • Adage Capital Partners's portfolio value rose 10% quarter-over-quarter to $71.3B.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.